Ribavirin [clinicaltrials_resource:c260972ef8fb801d491757e72eeceb79]
A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients [clinicaltrials:NCT00000699]Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients [clinicaltrials:NCT00000733]A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals [clinicaltrials:NCT00000772]A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children. [clinicaltrials:NCT00000833]A Study of Ribavirin in the Treatment of Patients With AIDS and AIDS-Related Problems [clinicaltrials:NCT00001015]A Collaborative Double-Blind Placebo-Controlled Trial of Intravenous Ribavirin As a Treatment for Presumed Hantavirus Pulmonary Syndrome [clinicaltrials:NCT00001123]Combination Drug Therapy for Patients With Hepatitis C [clinicaltrials:NCT00001729]Long-Term Therapy With Ribavirin for Chronic Hepatitis C [clinicaltrials:NCT00001854]The Safety and Effectiveness of Ribavirin in the Early Stages of HIV-Infection [clinicaltrials:NCT00002298]A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV) [clinicaltrials:NCT00008463]Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation [clinicaltrials:NCT00014391]Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection [clinicaltrials:NCT00015652]Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation [clinicaltrials:NCT00016081]clinicaltrials:NCT00018031Effects of Ribavirin on Zidovudine or Stavudine [clinicaltrials:NCT00021632]clinicaltrials:NCT00028093Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients [clinicaltrials:NCT00031473]Hepatitis C Antiviral Resistance in African-Americans [clinicaltrials:NCT00038974]clinicaltrials:NCT00039871Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) [clinicaltrials:NCT00051077]Treatment of Hepatitis C in Hemophilic Patients With HIV [clinicaltrials:NCT00055341]clinicaltrials:NCT00056862Zidovudine Levels in HIV Infected Patients Being Treated for HCV [clinicaltrials:NCT00059358]Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs [clinicaltrials:NCT00062816]ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection. [clinicaltrials:NCT00077636]A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC). [clinicaltrials:NCT00077649]clinicaltrials:NCT00081770CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders) [clinicaltrials:NCT00084279]clinicaltrials:NCT00085917Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy [clinicaltrials:NCT00086541]A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + Ribavirin [clinicaltrials:NCT00087568]A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program. [clinicaltrials:NCT00087594]REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination Therapy [clinicaltrials:NCT00087646]Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C [clinicaltrials:NCT00088504]Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive [clinicaltrials:NCT00093093]Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C [clinicaltrials:NCT00097045]A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C [clinicaltrials:NCT00097435]Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults [clinicaltrials:NCT00100581]clinicaltrials:NCT00100659clinicaltrials:NCT00104052
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Ribavirin [clinicaltrials_resource:c260972ef8fb801d491757e72eeceb79]
Bio2RDF identifier
c260972ef8fb801d491757e72eeceb79
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:c260972ef8fb801d491757e72eeceb79
identifier
clinicaltrials_resource:c260972ef8fb801d491757e72eeceb79
title
Ribavirin
@en
type
label
Ribavirin [clinicaltrials_resource:c260972ef8fb801d491757e72eeceb79]
@en